Histopathology of calcific aortic valve stenosis

Acta Cardiologica

Volumn 61, Issue 5, 2006, Pages 557-562

  Somers, Pamela ^a   Knaapen, Michiel ^a   Mistiaen, Wilhelm ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b Hogeschool   (Belgium)

Author keywords

Aortic valve stenosis; Calcification; Histopathology

Indexed keywords

GLUTARALDEHYDE;

AORTA VALVE STENOSIS; ARTERY CALCIFICATION; CELL DEATH; DISEASE COURSE; HEART VALVE PROSTHESIS; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIPID STORAGE; MORPHOLOGY; REVIEW;

AORTIC VALVE STENOSIS; CALCINOSIS; CELL DEATH; DISEASE PROGRESSION; HUMANS;

EID: 33750355675     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.5.2017772     Document Type: Review

References (40)

1. Mönckeberg JG. Der normale histologische Bau und die Sklerose der Aortenklappen. Virchows Arc Pathol Anat Physiol 1904; 176: 472-514.
2. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-5.
3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JM, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997; 29: 630-4.
4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-7.
5. Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984; 37: 407-15.
6. Aronow WS, Kronzon I. Correlation of prevalence and severity of valvular aortic stenosis determined by continuous-wave Doppler echocardiography with physical signs of aortic stenosis in patients aged 62 to 100 years with aortic systolic ejection murmurs. Am J Cardiol 1987; 60: 399-401.
7. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, Nagoh N, Kayaba K, Yamada S, Matsuo H. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995; 76: 928-32.
8. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001; 104: 2525-32.
9. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of degenerative valvular aortic stenosis: histologic and immunohistochemical studies. Circulation 1994; 90: 844-53.
10. Kaden JJ, Dempfle CE, Grobholz R, Fisher CS, Vocke DC, Kilic R, Sarikoc A, Pinol R, Hagl S, Lang S, Brueckmann M, Borggrefe M. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005; 14: 80-7.
11. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a) and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16: 523-32.
12. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19: 1218-22.
13. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-8.
14. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107: 2181-4.
15. Otto CM, O'Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001; 85: 601-2.
16. Mistiaen W, Van Cauwelaert P, Muylaert P, Sys SU, Harrisson F, Bortier H. Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2004; 127: 1166-70.
17. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990; 85: 1260-6.
18. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990; 87: 5134-8.
19. O'Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A. Comparison of apolipoprotein and proteoglycan deposits in human atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998; 98: 519-27.
20. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004; 286: 686-96.
21. Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper A, Binder T, Maurer G, Baumgartner H. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110: 1291-5.
22. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleuking-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23: 1162-70.
23. Somers P, Knaapen M, Kockx M, P van Cauwelaert, Bortier H, Mistiaen W. Histological evaluation of autophagic cell death in calcified aortic valve stenosis. J Heart Valve Dis 2006; 15: 43-8.
24. Jian B, Jones PL, Li Q, Mohler ER, Schoen FJ, Levy RJ. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 2001; 159: 321-7.
25. Satta J, Melkko J, Pollanen R, Tuukkanen J, Paakko P, Ohtonen P, Mennander A, Soini Y. Progression of human aortic valve stenosis is associated with tenascin-C expression. J Am Coll Cardiol 2002; 39: 96-101.
26. Vyavahare N, Jones PL, Tallapragada S, Levy RJ. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol 2000; 157: 885-93.
27. Kockx MM, Knaapen MWM. The role of apoptosis in vascular disease. J Pathol 2000; 190: 267-80.
28. Jian B, Narula N, Li QY, Mohler ER, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003; 75: 457-65.
29. Arounlangsy P, Sawabe M, Izumiyama N, Koike M. Histopathogenesis of early-stage mitral annular calcification. J Med Dent Sci 2004; 51: 35-44.
30. Martinet W, De Bie M, Schrijvers DM, De Meyer GRY, Herman AG, Kock MM. 7-Ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromh Vasc Biol 2004; 24: 2296-301.
31. Bostrom K, Watson KE, Stanford WP, Demer LL. Atherosclerotic calcification: relation to development osteogenesis. Am J Cardiol 1995; 75: 88B-91B.
32. Ortlepp JR, Schmitz F, Mevissen V, Weiss S, Huster J, Dronskowski R, Langebartels G, Autschbach R, Zerres K, Weber C, Hanrath P, Hoffmann R. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004; 25: 514-22.
33. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993; 7: 1475-82.
34. Robicsek F, Thubrikar MJ, Cook JW, Fowler B. The congenitally bicuspid aortic valve: how does it function? Why does it fail? Ann Thorac Surg 2004; 77: 177-85.
35. Carmody CJ, Burriesci G, Howard IC, Patterson EA. An approach to the stimulation of fluid-structure interaction in the aortic valve. J Biomech 2006; 39: 158-69.
36. Kim KM, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol 1999; 154: 843-52.
37. Gao G, Wu YX, Grunkemeier GL, Furnary AP, Starr A. Durability of pericardial versus porcine aortic valves. J Am Coll Cardiol 2004; 44: 384-8.
38. Logeais Y, Langanay T, Leguerrier A, Rioux C, Chaperon J, Coutte MB. Aortic Carpentier-Edwards supraannular porcine bioprothesis: a 12-year experience. Ann Thorac Surg 1999; 68: 421-5.
39. Stock UA, Vacanti JP, Mayer JE, Wahlers T. Tissue engineering of heart valves: current aspects. Thorac Cardiovasc Surg 2002; 50: 184-93.
40. Vesely I. Heart valve tissue engineering. Circ Res 2005; 97: 743-55.